Memorial Sloan Kettering Cancer Center (US)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
175
Publications
1489
Citations
208182
i10-index
548
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Improved Survival with Ipilimumab in Patients with... | 2010 | 15185 |
Combined Nivolumab and Ipilimumab or Monotherapy i... | 2015 | 8161 |
Mutational landscape determines sensitivity to PD-... | 2015 | 7816 |
Cancer immunotherapy using checkpoint blockade | 2018 | 6731 |
Overall Survival with Combined Nivolumab and Ipili... | 2017 | 5348 |
Ipilimumab plus Dacarbazine for Previously Untreat... | 2011 | 4509 |
Genetic Basis for Clinical Response to CTLA-4 Bloc... | 2014 | 4296 |
Nivolumab plus Ipilimumab in Advanced Melanoma | 2013 | 4227 |
Tumor mutational load predicts survival after immu... | 2019 | 4071 |
Melanoma exosomes educate bone marrow progenitor c... | 2012 | 3716 |
Jedd D. Wolchok is a researcher with 1489 publications and 208182 citations. They are affiliated with Memorial Sloan Kettering Cancer Center. Their research focuses on . With an h-index of 175, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Jedd D. Wolchok and 250M+ other papers.
Citations per publication by year